IBRX   $3.52  1.15% Market Closed After Close 3.51 -0.28%

Immunitybio Inc
Total Cash 217.98M
totalCashPerShare 0.313
EBITDA -341.06M
Total Debt 998.96M
quickRatio 3.543
currentRatio 3.91
Total Revenue 1.31M
debtToEquity
Revenue/Share 0.002
ROA -0.61037
ROE
grossProfits
freeCashflow -273.73M
operatingCashflow -410.00M
earningsGrowth
revenueGrowth 24.537
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -94.873924
profitMargins 0.0
enterpriseValue 3.28B
forwardPE -4.6959457
floatShares 165.47M
sharesOutstanding 696.53M
sharesShort 51.29M
sharesShortPriorMonth 46.77M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.77%
heldPercentInstitutions 0.09%
Short Ratio help_outline 15.74%
shortPercentOfFloat 0.32%
impliedSharesOutstanding
bookValue -1.01
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -597.65M
trailingEps -0.96%
forwardEps -0.74%
enterpriseToEbitda -9.60
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.17 3Q 2024
institutionsCount 259
lastUpdated Sept. 16, 2024, 8:16 p.m.